Veradigm | MDRX - Pre Tax Profit


Veradigm reported $35.3M in Pre-Tax Profit for its fiscal quarter ending in September of 2022.





Pre Tax Profit Change Date
Alcidion AUD 1.56M 1.77M Dec/2025
Ambu A/S DKK 157M 4M Mar/2026
Amplifon EUR 23.22M 3.12M Mar/2026
Cardinal Health USD 630M 32M Dec/2025
Centene USD 1.49B 613M Jun/2026
Charles River Laboratories USD -294.1M 464.13M Dec/2025
Cigna USD 2.27B 453M Mar/2026
Coloplast 1.79B 236M Dec/2025
Convatec Group USD 52M 6.3M Jun/2024
CVS Health USD 3.94B 2.58B Mar/2026
Diasorin EUR 62M 11.45M Mar/2026
Elevance Health USD 2.16B 146M Jun/2026
General Electric Aerospace USD 2.2B 654M Mar/2026
Humana USD 1.6B 2.61B Mar/2026
IQVIA Holdings USD 301M 5.92B Jun/2026
Laboratory Of America USD 8.73B 8.54B Mar/2026
Maximus USD 126.53M 267K Mar/2026
McKesson USD 1.63B 235M Dec/2025
Med Life RON 15.94M 4.07M Mar/2026
Molina Healthcare USD 112M 83M Jun/2026
Omnicell USD 16.9M 16.21M Mar/2026
Oriola-kd EUR 2.2M 7.8M Sep/2025
Owens Minor USD 35.71M 5.37M Sep/2025
Quest Diagnostics USD 334M 4M Mar/2026
Rede D'or Sao Luiz BRL 1.42B 74.95M Mar/2026
Siemens Healthineers EUR 644M 41M Mar/2026
Sonova Holding CHF 234.3M 159.4M Dec/2025
Supermax Corporation Bhd MYR -39.65M 103.39M Mar/2026
UnitedHealth USD 7.36B 600M Jun/2026
Veeva Systems USD 469.79M 152.26M Mar/2026
Veradigm USD 35.3M 13.95M Sep/2022
Xerox USD 299M 145M Mar/2026